Projects per year
Fingerprint Dive into the research topics where David Lovejoy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Kynurenine
Medicine & Life Sciences
Chelating Agents
Medicine & Life Sciences
Iron
Medicine & Life Sciences
Thiosemicarbazones
Chemical Compounds
Quinolinic Acid
Medicine & Life Sciences
Kynurenine 3-Monooxygenase
Chemical Compounds
Deferoxamine
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2013 2019
Macquarie University Centre for Motor Neuron Disease Research
Blair, I., Rowe, D., Guillemin, G., Chung, R., Atkin, J., Cole, N., Laird, A., Lim, C., Williams, K., Yang, S., Morsch, M., Lee, A., Shi, B., Walker, A., Lovejoy, D., Furlong, S., Adams, L., Syal, D., Bazzi, R., Svahn, A., Parakh, S., Shahheydari, H., Konopka, A., Ragagnin, A., Mehta, P., Wright, A., Bourbon, L., Sabaretnam, M., Don, E., Hortle, E., De Luca, A., Zhang, K., Tarr, I., Galper, J., Varney, B., Chow, S. & Formella, I.
1/01/17 → 31/12/19
Project: Research
Slowing progression of Alzheimer's disease by modulating the kynurenine pathway
Guillemin, G., Lovejoy, D., Ittner, A., Braidy, N., Doecke, J., Lim, C., Nicolazzo, J. & Ittner, L.
1/01/17 → 31/12/19
Project: Research
New directions for early diagnosis of MND: a large-scale longitudinal analysis of multiple biomarkers to find diagnostic and prognostic "fingerprints"
Guillemin, G., Rowe, D., Blair, I., Atkin, J., Zetterberg, H., Rogers, M., Lovejoy, D., Lim, C. & Tan, V.
1/01/18 → 31/12/18
Project: Research
New directions for early diagnosis of MND: a large-scale longitudinal analysis of multiple biomarkers to find diagnostic and prognostic 'fingerprints'
Guillemin, G., Rowe, D., Blair, I., Atkin, J., Lim, C., Lovejoy, D., Oytam, Y., Brew, B., Rodgers, K., Rogers, M., McCombe, P. A., Henderson, R. D., Woodruff, T., Ngo, S. & Tosolini, A.
1/06/16 → 31/08/17
Project: Research
Dermatoglyphics
Early Diagnosis
Appointments and Schedules
Biomarkers
Direction compound
New inhibitors of kynurenine-3-monooxygenase for Alzheimer's disease therapy
15/06/15 → 30/04/17
Project: Research
Kynurenine 3-Monooxygenase
Appointments and Schedules
Alzheimer Disease
Therapeutics
Research Outputs 1999 2019
Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer’s disease and relationship to amyloid-β and tau
Jacobs, K., Lim, C. K., Blennow, K., Zetterberg, H., Chatterjee, P., Martins, R. N., Brew, B., Guillemin, G. & Lovejoy, D., 1 Aug 2019, In : Neurobiology of Aging. 80, p. 11-20 10 p.Research output: Contribution to journal › Article › Research › peer-review
Kynurenine
Amyloid
Cerebrospinal Fluid
Alzheimer Disease
Quinolinic Acid
Kynurenine 3-monooxygenase activity in human primary neurons and effect on cellular bioenergetics identifies new neurotoxic mechanisms
Castellano-Gonzalez, G., Jacobs, K. R., Don, E., Cole, N. J., Adams, S., Lim, C. K., Lovejoy, D. B. & Guillemin, G. J., Apr 2019, In : Neurotoxicity Research. 35, 3, p. 530-541 12 p.Research output: Contribution to journal › Article › Research › peer-review
Kynurenine 3-Monooxygenase
Kynurenine
Human Activities
Energy Metabolism
Quinolinic Acid
Label-free fluorescent poly(amidoamine) dendrimer for traceable and controlled drug delivery
Wang, G., Fu, L., Walker, A., Chen, X., Lovejoy, D. B., Hao, M., Lee, A., Chung, R., Rizos, H., Irvine, M., Zheng, M., Liu, X., Lu, Y. & Shi, B., 13 May 2019, In : Biomacromolecules. 20, 5, p. 2148-2158 11 p.Research output: Contribution to journal › Article › Research › peer-review
Controlled drug delivery
Dendrimers
Cytotoxicity
Doxorubicin
Labels
Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: a pilot study
Chatterjee, P., Goozee, K., Lim, C. K., James, I., Shen, K., Jacobs, K. R., Sohrabi, H. R., Shah, T., Asih, P. R., Dave, P., ManYan, C., Taddei, K., Lovejoy, D. B., Chung, R., Guillemin, G. J. & Martins, R. N., 1 Dec 2018, In : Scientific Reports. 8, 1, p. 1-10 10 p., 8008.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Kynurenine
Amyloid
Serum
Alzheimer Disease
Social Adjustment
Development of a rapid fluorescence-based high-throughput screening assay to identify novel kynurenine 3-monooxygenase inhibitor scaffolds
Jacobs, K. R., Guillemin, G. J. & Lovejoy, D. B., 1 Jul 2018, In : SLAS Discovery. 23, 6, p. 554-560 7 p.Research output: Contribution to journal › Article › Research › peer-review
Kynurenine 3-Monooxygenase
High-Throughput Screening Assays
Scaffolds
Assays
Screening